What is the approximate market price of a box of lenvatinib/lenvatinib?

Lenvatinib is a multi-target tyrosine kinase inhibitor mainly used to treat various types of cancer. Its main indications include kidney cancer, liver cancer, thyroid cancer and certain types of endometrial cancer. Lenvatinib can effectively slow down the progression of tumors and improve patients' survival rate and quality of life by inhibiting the growth signals and angiogenesis of tumor cells.

In China, lenvatinib has been approved and marketed, and has been included in medical insurance, allowing patients to purchase it at domestic pharmacies. In the domestic market, the specification of lenvatinib is 4mg*30 tablets, and the price is about 3,000 yuan. Specific medical insurance reimbursement prices may vary, and patients are advised to consult at the local hospital pharmacy to obtain the most accurate information. The implementation of this medical insurance policy enables more patients to afford this important anti-cancer drug and reduces financial pressure.

In the international market, the price of the original drug of lenvatinib is generally higher, usually around RMB 2,000. However, with the advent of generic drugs, patients have more affordable treatment options. Currently, generic lenvatinib drugs produced in countries such as Laos and Bangladesh are already on the market, with prices ranging from 400 to 900 yuan. Although these generic drugs are low in price, they still need to pay attention to their quality and origin, and patients are advised to purchase them through regular channels.

The application of lenvatinib provides a new treatment option for cancer patients, especially when there is poor response to other therapies. Its multi-target characteristics make it effective in multiple tumor types. Through full communication with doctors, patients can develop personalized treatment plans and choose appropriate drugs and treatments based on their condition and financial status.

Reference materials:https://www.lenvima.com/